RNA Interference as a Tool for Exploring HIV-1 Robustness

被引:11
|
作者
Nevot, Maria [1 ]
Martrus, Gloria [1 ]
Clotet, Bonaventura [1 ]
Angel Martinez, Miguel [1 ]
机构
[1] Univ Autonoma Barcelona, Hosp Univ Germans Trias & Pujol, Fundacio irsiCaixa, Badalona 08916, Spain
关键词
RNAi; HIV-1; escape; evolution; IMMUNODEFICIENCY-VIRUS TYPE-1; ESCAPE; REPLICATION; INHIBITION; INFECTION; GENOME; EXPRESSION; EVOLUTION; PROGRESS;
D O I
10.1016/j.jmb.2011.08.035
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Short interfering RNAs (siRNAs) that target viral genes can efficiently inhibit human immunodeficiency virus type 1 (HIV-1) replication. Nevertheless, there is the potential for viral escape, particularly with a highly mutable target such as HIV-1. We present a novel strategy for anticipating and preventing viral escape using second-generation siRNAs. The evolutionary capacity of HIV-1 was tested by exerting strong selective pressure on a highly conserved sequence in the HIV-1 genome. We assayed the antiviral efficacy of five overlapping siRNAs directed against an essential region of the HIV-1 protease. Serial viral transfers in U87-CD4-CXCR4 cells were performed using four of the siRNAs. This procedure was repeated until virus breakthrough was detected. After several serial culture passages, resistant virus with a single point mutation in the targeted region was detected in the culture supernatants. The emergence of resistant virus was confirmed by molecular cloning and DNA sequencing of viral RNA. The most common escape route was the D30N mutation. Importantly, the addition of a second-generation siRNA that matched the D30N mutation restored viral inhibition and delayed development of escape variants. Passages performed with both siRNAs prevented the emergence of the D30N escape mutant and forced the virus to develop new escape routes. Thus, second-generation siRNAs can be used to block escape from RNA interference (RNAi) and to search for new RNAi escape routes. The protocol described here may be useful for exploring the sequence space available for HIV-1 evolution and for producing attenuated or deleterious viruses. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:84 / 96
页数:13
相关论文
共 50 条
  • [1] Combinatorial CRISPR-Cas9 and RNA Interference Attack on HIV-1 DNA and RNA Can Lead to Cross-Resistance
    Zhao, Na
    Wang, Gang
    Das, Atze T.
    Berkhout, Ben
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (12)
  • [2] Long-term inhibition of HIV-1 replication with RNA interference against cellular co-factors
    Eekels, Julia J. M.
    Geerts, Dirk
    Jeeninga, Rienk E.
    Berkhout, Ben
    ANTIVIRAL RESEARCH, 2011, 89 (01) : 43 - 53
  • [3] Control of HIV-1 replication by RNA interference
    Lee, NS
    Rossi, JJ
    VIRUS RESEARCH, 2004, 102 (01) : 53 - 58
  • [4] Toward a Durable Anti-HIV Gene Therapy Based on RNA Interference
    Berkhout, Ben
    OLIGONUCLEOTIDE THERAPEUTICS, 2009, 1175 : 3 - 14
  • [5] Antiviral Stratagems Against HIV-1 Using RNA Interference (RNAi) Technology
    Vlachakis, Dimitrios
    Tsiliki, Georgia
    Pavlopoulou, Athanasia
    Roubelakis, Maria G.
    Tsaniras, Spyridon Champeris
    Kossida, Sophia
    EVOLUTIONARY BIOINFORMATICS, 2013, 9 : 203 - 213
  • [6] Overcoming HIV-1 resistance to RNA interference
    Boden, Daniel
    Pusch, Oliver
    Ramratnam, Bharat
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2007, 12 : 3104 - 3116
  • [7] RNA Interference Targeted to the Conserved Dimerization Initiation Site (DIS) of HIV-1 Restricts Virus Escape Mutation
    Sugiyama, Ryuichi
    Habu, Yuichiro
    Ohnari, Aki
    Miyano-Kurosaki, Naoko
    Takaku, Hiroshi
    JOURNAL OF BIOCHEMISTRY, 2009, 146 (04) : 481 - 489
  • [8] RNA Interference Therapies for an HIV-1 Functional Cure
    Scarborough, Robert J.
    Gatignol, Anne
    VIRUSES-BASEL, 2018, 10 (01):
  • [9] RNA interference as an antiviral approach: Targeting HIV-1
    Berkhout, B
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2004, 6 (02) : 141 - 145
  • [10] Inhibition of drug-resistant HIV-1 by RNA interference
    Huelsmann, PM
    Rauch, P
    Allers, K
    John, MJ
    Metzner, KJ
    ANTIVIRAL RESEARCH, 2006, 69 (01) : 1 - 8